New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment

SH Chen, JY Chang - International journal of molecular sciences, 2019 - mdpi.com
Although cisplatin has been a pivotal chemotherapy drug in treating patients with various
types of cancer for decades, drug resistance has been a major clinical impediment. In …

[HTML][HTML] Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

C Li, X Xu, S Wei, P Jiang, L Xue… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Macrophages are the most important phagocytes in vivo. However, the tumor
microenvironment can affect the function and polarization of macrophages and form tumor …

Macrophage M2 polarization induced by exosomes from adipose-derived stem cells contributes to the exosomal proangiogenic effect on mouse ischemic hindlimb

D Zhu, TK Johnson, Y Wang, M Thomas… - Stem cell research & …, 2020 - Springer
Background M2 macrophages and exosomes from adipose-derived stem cells (ASCs) are
both reported to promote angiogenesis. However, the possible synergistic effects between …

Phenotypic impacts of CSF1R deficiencies in humans and model organisms

DA Hume, M Caruso, M Ferrari-Cestari… - Journal of leukocyte …, 2020 - academic.oup.com
Mϕ proliferation, differentiation, and survival are controlled by signals from the Mϕ CSF
receptor (CSF1R). Mono-allelic gain-of-function mutations in CSF1R in humans are …

Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy

SP Cheruku, V Rao, R Pandey… - International …, 2023 - Elsevier
Tumor-associated macrophages (TAMs) constitute the most prolific resident of the tumor
microenvironment (TME) that regulate its TME into tumor suppressive or progressive milieu …

[HTML][HTML] The evolving landscape of 'next-generation'immune checkpoint inhibitors: A review

L Mazzarella, BA Duso, D Trapani, C Belli… - European journal of …, 2019 - Elsevier
Abstract 'First-generation'immune checkpoint inhibitors targeting Cytotoxic T-Lymphocyte
Antigen 4 (CTLA4) and Programmed death-ligand 1 (PD (L) 1) have undoubtedly …

Functionalized nanoparticles targeting tumor-associated macrophages as cancer therapy

Y He, RF de Araújo Júnior, LJ Cruz, C Eich - Pharmaceutics, 2021 - mdpi.com
The tumor microenvironment (TME) plays a central role in regulating antitumor immune
responses. As an important part of the TME, alternatively activated type 2 (M2) macrophages …

Modeling CSF‐1 receptor deficiency diseases–how close are we?

V Chitu, Ş Gökhan, ER Stanley - The FEBS journal, 2022 - Wiley Online Library
The role of colony‐stimulating factor‐1 receptor (CSF‐1R) in macrophage and organismal
development has been extensively studied in mouse. Within the last decade, mutations in …

Discovery of BPR1R024, an orally active and selective CSF1R inhibitor that exhibits antitumor and immunomodulatory activity in a murine colon tumor model

KH Lee, WC Yen, WH Lin, PC Wang… - Journal of Medicinal …, 2021 - ACS Publications
Colony-stimulating factor-1 receptor (CSF1R) is implicated in tumor-associated macrophage
(TAM) repolarization and has emerged as a promising target for cancer immunotherapy …

Mutation of the PTCH1 gene predicts recurrence of breast cancer

CY Wang, YC Chang, YL Kuo, KT Lee, PS Chen… - Scientific reports, 2019 - nature.com
Breast cancer is the most common cancer in women, and some patients develop recurrence
after standard therapy. Effective predictors are urgently needed to detect recurrence earlier …